Tobramycin%252520eye%252520drop

# Tobramycin eye drop ## Overview Tobramycin is an aminoglycoside antibiotic formulated for ophthalmic use. It acts by inhibiting bacterial protein synthesis, providing broad-spectrum activity against many Gram-negative organisms (notably *Pseudomonas aeruginosa*) and some Gram-positive bacteria. ## Primary Indications * Bacterial conjunctivitis * External ocular infections (e.g., blepharitis, keratitis) caused by susceptible organisms. ## Adult Dosing * **Mild to Moderate Infections:** Instill 1 to 2 drops into the affected eye(s) every 4 hours. * **Severe Infections:** Instill 2 drops into the affected eye(s) every hour initially, tapering frequency as the infection is controlled. ## Pediatric Dosing * **Safety and Efficacy:** Safe for use in pediatric patients $\ge$ 2 months. Dosing is identical to adults (1 to 2 drops every 4 hours or as needed based on severity). ## Dose Adjustments * No specific renal or hepatic adjustments are required for topical ophthalmic administration due to negligible systemic absorption. ## Contraindications * Hypersensitivity to tobramycin or any component of the formulation. ## Adverse Effects * **Common:** Localized ocular irritation, burning, stinging, itching, or redness. * **Serious:** Hypersensitivity reactions (eyelid swelling, pruritus), corneal ulceration (with prolonged use), or secondary fungal infections. ## Key Drug Interactions * **Systemic Aminoglycosides:** If systemic aminoglycosides are administered concurrently, monitor for additive toxicity, though systemic absorption from eye drops is usually too low to cause significant interaction. * **Other Ophthalmic Preparations:** If using multiple eye medications, wait at least 5–10 minutes between applications. ## Monitoring * Monitor for clinical resolution of symptoms. * Discontinue use if signs of sensitivity occur. * Prolonged use may result in the overgrowth of non-susceptible organisms, including fungi; monitor for signs of secondary infection. ## Clinical Pearls * **Duration:** Typically prescribed for 7 days. Avoid prolonged use to prevent the development of resistant bacteria or sensitization. * **Administration:** Instruct patients to avoid touching the tip of the dropper to the eye, eyelids, or any surface to prevent contamination of the solution. * **Contact Lenses:** Patients should generally avoid wearing contact lenses while experiencing active bacterial conjunctivitis and during treatment. * **Uncertainty:** Dosing frequency for "severe" infections can vary by institution; always consult local infectious disease protocols or clinical pharmacists for specific facility guidelines on hourly dosing protocols. *** **Disclaimer:** This information is for educational purposes only and does not constitute medical advice. Always verify current prescribing information, institutional protocols, and patient-specific factors with verified medical resources or a licensed prescriber before administration.